Most recently, the value for artificial intelligence (AI)—enhanced simultaneous 18F-FDG PET/MRI for BC phenotyping, specifically for hormone receptor-positive (luminal) BC identification has been demonstrated [20]; nevertheless, its potential for the identification of TNBC remains unclear. The gene discussed is NR4A1; the disease is breast cancer.